{"entity":{"type":"insider","cik":"0001600023","url":"/insider/0001600023","json_url":"/insider/0001600023.json","name":"Phase4 Partners Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2018-02-01","last":"2018-02-07","span_basis":"filed_date"},"name_variants":[{"name":"Phase4 Partners Ltd","source":"filing","n_filings":2,"first_seen":"2018-02-01","last_seen":"2018-02-07"}],"transactions":[{"id":6686671,"accession":"0001140361-18-005596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-005596","line_url":"/filing/0001140361-18-005596#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":null,"owner_name":"PHASE4 VENTURES III GENERAL PARTNER Ltd; PHASE4 VENTURES III GP LP; PHASE4 VENTURES III LP; Phase4 Partners Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98500.0,"shares_display":"98,500","price_per_share":34.4006,"price_display":"34.40","price_state":"stated","total_value":3388459.1,"total_display":"3,388,459.10","shares_owned_after":1066947.0,"shares_owned_after_display":"1,066,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-07","scope":"insider"},{"id":6686669,"accession":"0001140361-18-005596","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-005596","line_url":"/filing/0001140361-18-005596#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":null,"owner_name":"PHASE4 VENTURES III GENERAL PARTNER Ltd; PHASE4 VENTURES III GP LP; PHASE4 VENTURES III LP; Phase4 Partners Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":37.0587,"price_display":"37.06","price_state":"stated","total_value":55588.05,"total_display":"55,588.05","shares_owned_after":1065447.0,"shares_owned_after_display":"1,065,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-07","scope":"insider"},{"id":6265859,"accession":"0001140361-18-004481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-004481","line_url":"/filing/0001140361-18-004481#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":null,"owner_name":"PHASE4 VENTURES III GENERAL PARTNER Ltd; PHASE4 VENTURES III LP; Phase4 Partners Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98500.0,"shares_display":"98,500","price_per_share":34.4006,"price_display":"34.40","price_state":"stated","total_value":3388459.1,"total_display":"3,388,459.10","shares_owned_after":1066947.0,"shares_owned_after_display":"1,066,947","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6265855,"accession":"0001140361-18-004481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-004481","line_url":"/filing/0001140361-18-004481#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":null,"owner_name":"PHASE4 VENTURES III GENERAL PARTNER Ltd; PHASE4 VENTURES III LP; Phase4 Partners Ltd","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":37.0587,"price_display":"37.06","price_state":"stated","total_value":55588.05,"total_display":"55,588.05","shares_owned_after":1065447.0,"shares_owned_after_display":"1,065,447","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Ten percent owner","n_filings":2,"first_seen":"2018-02-01","last_seen":"2018-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001600023","retrieved_at":"2026-08-21T21:36:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}